Is there still a role for fine‐needle aspiration cytology in breast cancer screening?

Pre-operative diagnostic procedures are adopted in the investigation ofsuspicious or equivocal screen-detected breast lesions to avoidunnecessary open biopsy. The high-quality performance of a nono-perative procedure provides the best benign-to-malignant ratio inopen biopsy. The quality assurance system is an integrated part ofbreast screening programs

[1]  M. Calaminici,et al.  Inadequate rates are lower when FNAC samples are taken by cytopathologists , 2003, Cytopathology : official journal of the British Society for Clinical Cytology.

[2]  W. P. Evans,et al.  Rate of insufficient samples for fine‐needle aspiration for nonpalpable breast lesions in a multicenter clinical trial , 1998, Cancer.

[3]  J. Lamb,et al.  Role of fine needle aspiration cytology in breast cancer screening. , 1987, Journal of clinical pathology.

[4]  L. Irwig,et al.  Likelihood ratios for clinical examination, mammography, ultrasound and fine needle biopsy in women with breast problems , 1998 .

[5]  K. Chew,et al.  Diagnostic accuracy of fine‐needle aspiration biopsy is determined by physician training in sampling technique , 2001, Cancer.

[6]  N. Sneige,et al.  Changing trends in breast fine‐needle aspiration: Results of the Papanicolaou society of cytopathology survey , 2000, Diagnostic cytopathology.

[7]  S. Ciatto.  Real time reading in mammography breast screening , 2007, La radiologia medica.

[8]  S. Tabbara,et al.  The spectrum of cytologic features in nonproliferative breast lesions , 2001, Cancer.

[9]  J. Groenewoud,et al.  A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer , 2007, Breast Cancer Research and Treatment.

[10]  J. Litherland.  Should fine needle aspiration cytology in breast assessment be abandoned? , 2002, Clinical radiology.

[11]  D. Ravichandran,et al.  Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma , 2006, British Journal of Cancer.

[12]  L L Fajardo,et al.  Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. , 2001, Radiology.

[13]  S. Tabbara,et al.  Cytologic features of proliferative breast disease , 2000, Cancer.

[14]  S. Ciatto,et al.  Minority report – false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis , 2007, Breast Cancer Research and Treatment.

[15]  C. Woodman,et al.  Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial , 2018 .

[16]  M. Dray,et al.  Improved fine needle aspiration (FNA) cytology results with a near patient diagnosis service for breast lesions , 2000, Cytopathology : official journal of the British Society for Clinical Cytology.

[17]  F. E. White,et al.  Fine needle aspiration cytology in the UK breast screening programme: a national audit of results. , 1999, Breast.

[18]  T. Levine.  Breast cytology – is there still a role? , 2004, Cytopathology : official journal of the British Society for Clinical Cytology.

[19]  S. Ciatto,et al.  Positive predictive value of breast fine needle aspiration cytology (FNAC) in combination with clinical and imaging findings: a series of 2334 subjects with abnormal cytology , 2006, Breast Cancer Research and Treatment.

[20]  Prabodh K. Gupta,et al.  Diagnostic value and cost‐effectiveness of on‐site evaluation of fine‐needle aspiration specimens: Review of 5,688 cases , 2002, Diagnostic cytopathology.

[21]  Ben Davidson,et al.  Fine‐needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions , 2003, Diagnostic cytopathology.

[22]  S. A. Ray,et al.  Immediate cytodiagnosis and imaging in the clinical management of discrete benign breast lesions. , 1997, Annals of the Royal College of Surgeons of England.